Anavex Life Sciences Corp (AVXL)

[falconer66a]

Yes, trial results will move the stock.

Nothing to move this stock until Rett approval or alz data, probably nothing this year.

That is very likely to be the case. Not many people buying equities read (or understand) what appears in Nature.

But the paper's findings accurately project that the Rett syndrome trial data will be positive; allowing the FDA to then approve blarcamesine for that horrible disease, as the authors of the paper state. That, FDA approval, of course, will move the stock.

I can wait. Will be very well rewarded.